Wild-Type Huntingtin Plays a Role in Brain Development and Neuronal Survival

Molecular Neurobiology

Volumn 28, Issue 3, 2003, Pages 259-275

  Reiner, Anton ^a   Dragatsis, Ioannis ^a   Zeitlin, Scott ^b   Goldowitz, Daniel ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Basal ganglia; Colonization; Cortex; Development; HD gene; Huntington's Disease

Indexed keywords

HUNTINGTIN;

BRAIN DEVELOPMENT; CHOREA; EMBRYO DEVELOPMENT; GENE DELETION; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; LETHALITY; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; REVIEW; SURVIVAL; WILD TYPE;

EID: 0742304252     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/MN:28:3:259     Document Type: Review

References (89)

1. Albin R. L. and Tagle D. A. (1995) Genetics and molecular biology of HD. Trends Neurosci. 18, 11-14.
2. Altar C. A., Cai N., Bliven T., et al. (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389, 856-860.
3. Ambrose C. M., Duyao M. P., Barnes G., et al. (1994) Evidence against simple inactivation due to an expanded CAG repeat. Somat. Cell Molec. Genet. 20, 27-38.
4. Aronin N., Kim M., Laforet G., and DiFiglia M. (1999) Are there multiple pathways in the pathogenesis of Huntington's disease? Phil. Trans. R. Soc. Lond. B. 354, 995-1003.
5. Auerbach W., Hurlbert M. S., Hilditsch-Maguire P., et al. (2001) The HD mutation causes progressive neurological disease in mice expressing reduced levels of huntingtin. Hum. Mol. Gen. 10, 2515-2523.
6. Bence N. F., Sampat R. M., and Kopito R. R. (2001) Impairment of the ubiquitin-proteosome system by protein aggregation. Science 292, 1552-1555.
7. Bhide P. G., Day M., Sapp E., et al. (1996) Expression of normal and mutant Huntingtin in the developing brain. J. Neurosci. 16, 5523-5535.
8. Bruyn G. W. and Went L. N. (1986) Huntington's chorea, In Handbook of Clinical Neurology, vol. 49 Extrapyramidal Disorders, revised series 5 (Vinken P. J., Bruyn G. W., and Klawans H. L., eds.) Elsevier Science Publishers, Amsterdam, Netherlands, pp. 267-313.
9. Cattaneo E. Rigamonti D. Goffredo D. Zuccato C. Squitieri F., and Sipione S. (2001) Loss of normal huntingtin function: new developments in Huntington's disease research. Trends Neurosci. 24, 182-188.
10. Cha J. H., Kosinski C. M., Kerner J. A., et al. (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc. Natl. Acad. Sci. USA 95, 6480-6485.
11. Chai Y., Koppenhafer S. L., Shoesmith S. J., Perez M. K., and Paulson H. L. (1999) Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet. 8, 673-682.
12. Conneally P. M. (1984) Huntington Disease: Genetics and epidemiology. Am. J. Hum. Genet. 36, 506-526.
13. Davies S. W., Turmaine M., Cozens B. A., et al. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
14. De La Monte S. M., Vonsattel J. P., and Richardson E. P. Jr. (1988) Morphometric demonstrations of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 516-525.
15. DiFiglia M., Sapp E., Chase K., et al. (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075-1081.
16. DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P., and Aronin J. P. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
17. Dorsman J. C., Smoor M. A., Maat-Schieman M. L. C, et al. (1999) Analysis of the subcellular localization of huntingtin with a set of rabbit polyclonal antibodies in cultured mammalian cells of neuronal origin: comparison with distribution of huntingtin in Huntington's disease autopsy brain. Phil. Trans. R. Soc. Lond. 354, 1061-1067.
18. Dragatsis I., Efstratiadis A., and Zeitlin S. (1998) Mouse mutant embryos lacking huntingtin are rescued from lethality by wild-type extraembryonic tissues. Development 125, 1529-1539.
19. Dragatsis I., Levine M., and Zeitlin S. (2000) Inactivation of the mouse Huntington's disease gene in the brain and testis results in progressive neurodegeneration and sterility. Nature Genet. 26, 300-306.
20. Dragatsis I. and Zeitlin S. (2000) CaMKllalpha-Cre transgene expression and recombination patterns in the mouse brain. Genesis 26, 133-135.
21. Duyao M. P., Auerbach A. B., Ryan A., et al. (1995) Inactivation of the mouse HD gene homolog Hdh. Science 269, 407-410.
22. Fusco F. R., Chen Q., Lamoreaux W. J., et al. (1999) Cellular localization of huntingtin in striatal and cortical neurons in rats: Lack of correlation with neuronal vulnerability in Huntington's disease. J. Neurosci. 19, 1189-1202.
23. Gervais F. G., Singaraja R., Xanthoudakis S., et al. (2002) Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nature Cell Biol. 4, 95-105.
24. Gusella J. F. and MacDonald M. E. (1996) Trinucleotide instability: A repeating theme in human inherited disorders. Ann. Rev. Med. 47, 201-209.
25. Gutekunst C. A., Levey A. I., Heilman C. J., et al. (1995) Identification and localization of huntigtin in brain and hman lymphoblastoid cell lines with anti-fusion protein antibodies. Proc. Natl. Acad. Sci. USA 92, 8710-8714.
26. Gutekunst C. A., Li S. H., Yi H., et al. (1999) Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 19, 2522-2534.
27. Hackam A. S., Wellington C. L., and Hayden M. R. (1998) The fatal attraction of polyglutamine-containing proteins. Clin. Gen. 53, 233-242.
28. Hackam A. S., Yassa A. S., Singaraja R., et al. (2000) Huntingtin interacting protein 1 induces apoptosis via novel caspase-dependent death effector domain. J. Biol Chem. 275, 41,299-41,308.
29. Hebb M. O., Denovan-Wright E. M., and Robertson H. A. (1999) Expression of the Huntinton's disease gene is regulated in astrocytes in the arcuate nucleus of the hypothalamus of postpartum rats. FASEB 9, 1099-1106.
30. Hedreen J. C., Peyser C. E., Folstein S. E., and Ross C. A. (1991) Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci. Lett. 133, 257-261.
31. Hodgson J. G., Agopyan N., Gutekunst C. A., et al. (1999) A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23, 181-192.
32. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on the HD chromosome. Cell 72, 971-983.
33. Lvkovic S. and Ehrlich M. E. (1999) Expression of the striatal DARPP-32/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro. J. Neurosci. 19, 5409-5419.
34. Kalchman M. A., Koide H. B., McCutcheon K., et al. (1997) HIP1: A human homologue of S. cerevisiae sla2p interacts with membrane-associated huntingtin in the brain. Nat. Genet. 16, 44-53.
35. Kegel K. B., Kim M., Sapp E., McIntyre C., Castano J. C., Aronin N., and DiFiglia M. (2000) Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J. Neurosci. 20, 7268-7278.
36. Kegel K. B., Meloni A. R., Yi Y., et al. (2002) Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J. Biol. Chem. 277, 7466-7476.
37. Kim T. W. and Tanzi R. E. (1998) Neuronal intranuclear inclusions in polyglutamine diseases: nuclear weapons or nuclear fallout. Neuron 21, 657-659.
38. Ko J., Ou S., and Patterson P. H. (2001) New anti-huntingtin monoclonal antibodies: Implications for huntingtin conformation and its binding proteins. Brain Res. Bull. 56, 319-329.
39. Landwehrmeyer G. B., McNeil S. M., Dure IV L. S., et al. (1995) HD gene: regional and cellular expression in brain of normal and affected individuals. Ann. Neurol. 37, 218-230.
40. Leavitt B. R., Guttman J. A., Hodgson J. G., et al. (2001) Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo. Am. J. Hum. Genet. 68, 313-324.
41. Li S. H. and Li X. J. (1998) Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. Human Mol. Gen. 7, 801-806.
42. Li S. H., Schilling G., Young W. S. III, et al. (1993) HD gene (IT15) is widely expressed in human and rat tissues. Neuron 11, 985-993.
43. Luthi-Carter R., Hanson S., Strand A. D., et al. (2002) Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Human Mol. Genet. 11, 1911-1926.
44. Maat-Schieman M. L. C., Dorsman J. C., Smoor M. A., et al. (1999) Distribution of inclusions in neuronal nuclei and dystrophic neuntes in Huntington's disease brain. J. Neuropath. Exp. Neurol. 58, 129-137.
45. Martindale D., Hackam A., Wieczorek A., et al. (1998) Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nature Gen. 18, 150-154.
46. Mehler M. F. and Gokhan S. (2000) Mechanisms underlying neural cell death in neurodegenerative diseases: alterations of a developmentally mediated cellular rheostat. Trends Neurosci. 23, 599-605.
47. Mehler M. F. and Gokhan S. (2001) Developmental mechanisms in the pathogenesis of neurodegenerative diseases. Prog. Neurobiol. 63, 337-363.
48. Metzler M., Chen N., Helgason C. D., et al. (1999) Life without huntingtin: Normal differentiation into functional neurons. J. Neurochem. 72, 1009-1018.
49. Moens C. B., Cordes S. P., Giorgianni M. W., Barsh G. S., and Kimmel C. B. (1998) Equivalence in the genetic control of hindbrain segmentation in fish and mouse. Development 125, 381-391.
50. Myers R. H., Leavitt J., Farrer L. A., et al. (1989) Homozygote for Huntington's Disease. Am. J. Hum. Genet. 45, 615-618.
51. Narain Y., Wyttenbach A., Rankin J., Furlong R. A., and Rubinsztein D. C. (1999) A molecular investigation of true dominance in Huntington's disease. J. Med. Genet. 36, 739-746.
52. Nasir J., Floresco S. B., O'Kusky J. R., et al. (1995) Targeted disruption of the HD gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81, 811-823.
53. Nucifora F. C. Jr., Sasaki M., Peters M. F., et al. (2001) Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science 291, 2423-2428.
54. Ona V. O., Li M., Vonsattel J. P., et al. (1999) Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399, 263-267.
55. Persichetti F., Carlee L., Faber P. W., et al. (1996) Differential expression of normal and mutant Huntington's disease gene alleles. Neurobiol. Dis. 3, 183-190.
56. Petersén Å., Larsen K. E., Behr G. G., Romero N., Przedborski S., Brundin P., and Sulzer D. (2001) Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum. Mol. Genet. 10, 1243-1254.
57. Preisinger E., Jordan B. M., Kazantsev A., and Housman D. (1999) Evidence for a recruitment and sequestration mechanism in Huntinton's disease. Phil. Trans. Royal Soc. Lond. 354, 1029-1034.
58. Reiner A., Del Mar N., Meade C. A., Yang H., Dragatsis I., Zeitlin S., and Goldowitz D. (2001) Neurons lacking huntingtin differentially colonize brain and survive in chimeric mice. J. Neurosci. 21, 7608-7618.
59. Rigamonti D., Bauer J. H., De-Fraja C., et al. (2000) Wild-type huntingtin protects from apoptosis upstream of caspase-3. J. Neurosci. 20, 3705-3713.
60. Rigamonti D., Sipione S., Goffredo D., Zuccato C., Fossale E., and Cattaneo E. (2001) Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing. J. Biol. Chem. 276, 14,545-14,548.
61. Roos R. A. C. (1986) Neuropathology of Huntington's Chorea, In: Handbook of Clinical Neurology, vol. 49 Extrapyramidal Disorders, revised series 5 (Vinken P. J., Bruyn G. W., and Klawans H. L., eds.) Elsevier Science Publishers, Amsterdam, Netherlands, pp. 315-326.
62. Rosas H. D., Liu A. K., Hersch S., et al. (2002) Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 58, 695-701.
63. Ross C. A. (2002) Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 35, 819-822.
64. Ross C. A., Margolis R. L., Belcher M. W., Wood J. D., Engelender S., and Sharp A. H. (1998) Pathogenesis of polyglutamine neurodegenerative diseases: Toward a unifying hypothesis, In: Genetic Instabilities and Hereditary Neurological Disease (Wells R., ed.) Academic Press, New York, pp. 761-776.
65. Sanchez I., Xu C. J., Juo P., Kakizaka A., Bienis J., and Yuan J. (1999) Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22, 623-633.
66. Sapp E., Schwarz C., Chase K., et al. (1997) Huntingtin localization in brains of normal and HD patients. Ann. Neurol. 42, 604-612.
67. Saudou F., Finkbeiner S., Devys D., and Greenberg M. E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66.
68. Schilling G., Sharp A. H., Loev S. J., Wagster M. V., Li S. H., Stine O. C., and Ross C. A. (1995) Expression of the Huntington's disease (IT15) protein product in HD patients. Human Molec. Gen. 4, 1365-1371.
69. Schuman E. M. (1999) Neurotrophin regulation of synaptic transmission. Curr. Opin. Neurobiol. 9, 105-109.
70. Sharp A. H. and Ross C. A. (1996) Neurobiology of Huntington's Disease. Neurobiol. Dis. 3, 3-15.
71. Sharp A. H., Loev S. J., Schilling G., et al. (1995) Widespread expression of HD gene (IT15) protein product. Neuron 14, 1065-1074.
72. Shieh P. B., Hu S. C., Bobb K., Timmusk T., and Ghosh A. (1998) Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 20, 727-740.
73. Sisodia S. S. (1998) Nuclear inclusion in glutamine repeat disorders: Are they pernicious, coincidental or beneficial? Cell 95, 1-4.
74. Squitieri F., Gellera C., Cannella M., et al. (2003) Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain 126, 946-955.
75. Storey E., Kowall N. W., Finn S. F., Mazurek M. F., and Beal M. F. (1992) The cortical lesion of Huntington's disease: further neurochemical characterization and reproduction of some of the histological and neurochemical features by N-Methyl-D-Aspartate. Ann. Neurol. 32, 526-534.
76. Strong T. V., Tagle D. A., Valdes J. M., et al. (1993) Widespread expression of the human and rat Huntington's disease gene in brain and non-neural tissues. Nat. Genet. 5, 259-265.
77. Tao X., Finkbeiner S., Arnold D. B., Shaywitz A., and Greenberg M. E. (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20, 709-726.
78. Velier J., Kim M., Schwarz C., Kim T. W., Sapp E., Chase K., Aronin N., and DiFiglia M. (1998) Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytotic pathways. Exp. Neurol. 152, 34-40.
79. Vonsattel J. P. and DiFiglia M. (1998) Huntington Disease. J. Neuropathol. Exp. Neurol. 57, 369-384.
80. Vonsattel J. P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D., and Richardson E. P. (1985) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577.
81. Wexler N. S., Young A. B., Tanzi R. E., et al. (1987) Homozygotes for Huntington's Disease. Nature 326, 194-197.
82. Wheeler V. C., White J. K., Gutekunst C. A., et al. (2000) Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum. Mol. Genet. 9, 503-513.
83. White J. K., Auerbach W., Duyao M. P., Vonsattel J. P., Gusella J. F., Joyner A. L., and MacDonald M. E. (1997) Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nature Genet. 17, 404-410.
84. Wilkinson F. L., Man N. T., Manual S. B., Thomas P., Neal J. W., Harper P. S., Jones A. L., and Morris G. E. (1999) Localization of rabbit huntingtin using a new panel of monoclonal antibodies. Mol. Brain Res. 69, 10-20.
85. Wilson R. S., Como P. G., Garron D. C., Klawans H. L., Barr A., and Klawans D. (1987) Memory failure in Huntington's disease. J. Clin. Exp. Neuropsychol. 9, 147-154.
86. Wood J. D., McLaughlin J. C., Harper P. S., Lowenstein P. R., and Jones A. L. (1996) Partial characterization of murine huntingtin and apparent variations in the subcellular localization of huntingtin in human, mouse and rat brain. Hum. Molec. Genet. 5, 481-487.
87. Zeitlin S., Liu J. P., Chapman D. L., Papaioannou V. E., and Efstratiadis A. (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the HD gene homologue. Nature Genet. 11, 155-163.
88. Zeron M. M., Hansson O., Chen N., Wellington C. L., Leavitt B. R., Brundin P., Hayden M. R., and Raymond L. A. (2002) Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 33, 849-860.
89. Zuccato C., Ciammola A., Rigamonti D., et al. (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293, 493-498.